{"id":53094,"date":"2023-01-19T14:02:13","date_gmt":"2023-01-19T13:02:13","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\/"},"modified":"2023-01-19T14:02:13","modified_gmt":"2023-01-19T13:02:13","slug":"twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\/","title":{"rendered":"Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023"},"content":{"rendered":"
\n

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2023 first quarter ended December 31, 2022, before the opening of the market on Friday, February 3, 2023. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financial results and provide an update on the company\u2019s business. The press release with the financial results will be accessible from the company\u2019s website prior to the conference call through the Investor Relations section under the \u201cCompany\u201d tab at www.twistbioscience.com<\/a>.\n<\/p>\n

<\/a><\/p>\n

\nThe conference call will be webcast live through the Investor Relations section under the \u201cCompany\u201d tab at www.twistbioscience.com<\/a>. Those parties interested in participating via telephone must register on the Company\u2019s Investor Relations website or by clicking here<\/a>. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast replay will be available for two weeks.\n<\/p>\n

\nAbout Twist Bioscience Corporation<\/b>\n<\/p>\n

\nTwist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by \u201cwriting\u201d DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.\n<\/p>\n

\nFollow us on Twitter<\/a> | Facebook<\/a> | LinkedIn<\/a> | YouTube<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor Twist Bioscience:<\/b>
Angela Bitting
\n
SVP, Corporate Affairs
\n
925-202-6211
\n
abitting@twistbioscience.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2023 first quarter ended December 31, 2022, before the opening of the market on Friday, February 3, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53094","6":"format-standard","7":"category-industry"},"yoast_head":"\nTwist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2023 first quarter ended December 31, 2022, before the opening of the market on Friday, February 3, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-19T13:02:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230119005343\/en\/1121919\/21\/Twist_Bioscience_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023\",\"datePublished\":\"2023-01-19T13:02:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\\\/\"},\"wordCount\":368,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230119005343\\\/en\\\/1121919\\\/21\\\/Twist_Bioscience_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\\\/\",\"name\":\"Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230119005343\\\/en\\\/1121919\\\/21\\\/Twist_Bioscience_Logo.jpg\",\"datePublished\":\"2023-01-19T13:02:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230119005343\\\/en\\\/1121919\\\/21\\\/Twist_Bioscience_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230119005343\\\/en\\\/1121919\\\/21\\\/Twist_Bioscience_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\/","og_locale":"en_US","og_type":"article","og_title":"Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023 - Pharma Trend","og_description":"SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2023 first quarter ended December 31, 2022, before the opening of the market on Friday, February 3, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-19T13:02:13+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230119005343\/en\/1121919\/21\/Twist_Bioscience_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023","datePublished":"2023-01-19T13:02:13+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\/"},"wordCount":368,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230119005343\/en\/1121919\/21\/Twist_Bioscience_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\/","url":"https:\/\/pharma-trend.com\/en\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\/","name":"Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230119005343\/en\/1121919\/21\/Twist_Bioscience_Logo.jpg","datePublished":"2023-01-19T13:02:13+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230119005343\/en\/1121919\/21\/Twist_Bioscience_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230119005343\/en\/1121919\/21\/Twist_Bioscience_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/twist-bioscience-to-report-fiscal-2023-first-quarter-financial-results-on-friday-february-3-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53094","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53094"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53094\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53094"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53094"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53094"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}